Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 39-47

  Holick, Crystal N ^a   Smith, Scott G ^b   Giovannucci, Edward ^a,b,c   Michaud, Dominique S ^a,d  

^a Department of Epidemiology ^*  (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CANCER RISK; CARBONATED BEVERAGE; COFFEE; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; TEA;

ADULT; AGED; BRAIN NEOPLASMS; CAFFEINE; COFFEE; COHORT STUDIES; DIET; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK; TEA;

EID: 74549170874     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0732     Document Type: Article

References (34)

1. Nehlig A, Debry G. Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review. Mutat Res 1994;317:145-62.
2. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992;17: 139-70.
3. Lunt MJ, Ragab S, Birch AA, Schley D, Jenkinson DF. Comparison of caffeine-induced changes in cerebral blood flow and middle cerebral artery blood velocity shows that caffeine reduces middle cerebral artery diameter. Physiol Meas 2004;25:467-74.
4. Croft KD. The chemistry and biological effects of flavonoids and phenolic acids. Ann N Y Acad Sci 1998;854:435-42.
5. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:2073-85S.
6. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007;132:1740-5.
7. Efird JT, Friedman GD, Sidney S, et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette-smoking and other lifestyle behaviors. JNeurooncol 2004;68:57-69.
8. Hochberg F, Toniolo P, Cole P, Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 1990;8:55-60.
9. Burch JD, Craib KJ, Choi BC, et al. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987;78:601-9.
10. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997;8:13-24.
11. Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 1997;8:5-12.
12. Giles GG, McNeil JJ, Donnan G, et al. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994;59:357-62.
13. Belanger CF, Hennekens CH, Rosner B, Speizer FE. The Nurses' Health Study. Am J Nurs 1978;78:1039-40.
14. Colditz G. The Nurses' Health Study: findings during 10 years of follow-up of a cohort of U.S. women. Curr Prob in Obstet Gynecol Fertil 1990;13:130-74.
15. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
16. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
17. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
18. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99.
19. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18:858-67.
20. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984;119:837-9.
21. 2 tests for linear trends in proportions. Biometrics 1968;24:315-27.
22. Willett WC. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press; 1998.
23. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-40.
24. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
26. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998-2002: Central Brain Tumor Registry of the United States. 2005.
27. Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
28. Ascherio A, Chen H, Schwarzschild MA, et al. Caffeine, post-menopausal estrogen, and risk of Parkinson's disease. Neurology 2003; 60:790-5.
29. Ascherio A, Weisskopf MG, O'Reilly EJ, et al. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 2004;160:977-84.
30. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003;133:3275-84S.
31. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
32. Ju J, Lu G, Lambert JD, Yang CS. Inhibition of carcinogenesis by tea constituents. Semin Cancer Biol 2007;17:395-402.
33. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996;34:119-29.
34. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 2007;247:26-39.